Literature DB >> 9262334

Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels.

J H Song1, C S Huang, K Nagata, J Z Yeh, T Narahashi.   

Abstract

The effects of riluzole, a neuroprotective drug, on tetrodotoxin-sensitive (TTX-S) and tetrodotoxin-resistant (TTX-R) sodium channels in rat dorsal root ganglion neurons were studied using the whole-cell patch clamp technique. At the resting potential, riluzole preferentially blocked TTX-S sodium channels, whereas at more negative potentials, it blocked both types of sodium channels almost equally. The apparent dissociation constants for riluzole to block TTX-S and TTX-R sodium channels in their resting state were 90 and 143 microM, respectively. Riluzole shifted the voltage dependence of activation of TTX-R sodium channels in the depolarizing direction more than that of TTX-S sodium channels. The voltage dependence of the fast inactivation of both types of sodium channels was shifted in the hyperpolarizing direction in a dose-dependent manner, and the apparent dissociation constants for riluzole to block the inactivated channels were estimated to be 2 and 3 microM for the TTX-S and TTX-R sodium channels, respectively, indicating a much higher affinity for the inactivated channels than for the resting channels. Riluzole was equally effective in blocking both types of sodium channels in their slow inactivated state. Since more TTX-S channels are inactivated than TTX-R channels at the resting potential, riluzole blocks TTX-S sodium channels more potently than TTX-R sodium channels. It was concluded that one of the mechanisms by which riluzole exerts its neuroprotective action is to preferentially block the inactivated sodium channel of damaged or depolarized neurons under ischemic conditions, thereby suppressing excess stimulation of the glutamatergic receptors and massive influx of Ca++.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262334

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  46 in total

1.  Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones.

Authors:  J J Kuo; R H Lee; L Zhang; C J Heckman
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

2.  Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival.

Authors:  Alice Y C Liu; Rohan Mathur; Newton Mei; Christopher G Langhammer; Bruce Babiarz; Bonnie L Firestein
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

3.  Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Mol Pharmacol       Date:  2011-07-25       Impact factor: 4.436

4.  Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole.

Authors:  Jeffrey D Erickson
Journal:  J Neurochem       Date:  2017-05-18       Impact factor: 5.372

5.  The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.

Authors:  Nichole Coleman; Hai M Nguyen; Zhengyu Cao; Brandon M Brown; David Paul Jenkins; Dorota Zolkowska; Yi-Je Chen; Brian S Tanaka; Alan L Goldin; Michael A Rogawski; Isaac N Pessah; Heike Wulff
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

6.  Bursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglion.

Authors:  W Xie; J A Strong; D Kim; S Shahrestani; J-M Zhang
Journal:  Neuroscience       Date:  2012-01-11       Impact factor: 3.590

Review 7.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

8.  Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.

Authors:  Ananthakrishnan Sankaranarayanan; Girija Raman; Christoph Busch; Tim Schultz; Pavel I Zimin; Joachim Hoyer; Ralf Köhler; Heike Wulff
Journal:  Mol Pharmacol       Date:  2008-10-27       Impact factor: 4.436

9.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 10.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.